Startup Valuation Methods: How VCs Value Early-Stage Companies

Why Startup Valuation Is Different from Public Company Valuation

Public companies get valued on earnings, EBITDA multiples, and discounted cash flows. Early-stage startups have none of those. Most pre-seed and seed companies have no revenue, no profits, and projections that are largely guesses.

So VCs use a different toolkit. They're not valuing what the company is today — they're pricing the option to own a piece of what it might become. That makes early-stage valuation part art, part benchmark, and part negotiation.

The Five Main Valuation Methods for Early-Stage Startups

Berkus Method

Developed by angel investor Dave Berkus in the 1990s and updated for modern markets, the Berkus Method assigns up to $2.5M of value to each of five factors:

• Sound idea (basic value) — up to $2.5M
• Working prototype (reducing technology risk) — up to $2.5M
• Quality management team (reducing execution risk) — up to $2.5M
• Strategic relationships (reducing market risk) — up to $2.5M
• Product rollout or sales (reducing production risk) — up to $2.5M

Maximum pre-money valuation: $12.5M. In practice, most pre-revenue companies score $3–7M under this method. Note that Berkus himself has updated the thresholds over time — some practitioners now use $3–5M per factor to reflect current market conditions.

Scorecard Method

Also called the Ohio or Bill Payne method. Start with the median pre-money valuation for comparable startups in your region and sector. Then apply a weighted multiplier based on how your company compares on key dimensions:

• Team strength — 30% weight
• Size of opportunity — 25% weight
• Product / technology — 15% weight
• Competitive environment — 10% weight
• Marketing / sales channels — 10% weight
• Need for additional investment — 5% weight
• Other factors — 5% weight

If the regional median is $5M and your weighted score is 1.2 (20% better than average), your valuation is $6M. Simple but calibrated to actual deal data.

Risk Factor Summation

Start with a benchmark (again, regional median). Then add or subtract $250K for each of 12 risk categories based on whether the company is above or below average:

• Management risk, stage of the business, legislation/political risk, manufacturing risk
• Sales/marketing risk, funding/capital raising risk, competition risk, technology risk
• Litigation risk, international risk, reputation risk, exit value risk

A perfect score adds $3M. The worst possible score subtracts $3M. Most companies land within $1.5M of the benchmark.

Revenue Multiples by Sector and Stage

Once a startup has meaningful ARR (typically $500K+), investors shift toward revenue multiples. According to PitchBook's 2024 Venture Monitor, multiples compressed significantly from 2021 highs but have partially recovered. These are approximate 2024–2026 ranges:

AI infrastructure companies command the highest multiples right now — driven by demand for GPU capacity, model APIs, and developer tooling. According to NVCA's 2024 Yearbook, AI-focused deals accounted for 37% of all venture dollars invested in 2023, up from 15% in 2020.

Pre-Money vs. Post-Money Valuation

This distinction trips up almost every first-time founder.

Pre-money valuation is the value of your company before the new investment comes in. Post-money valuation is pre-money plus the new capital.

The $2M difference in pre-money valuation costs you 5 additional points of equity — worth potentially millions at exit. Always clarify whether a term sheet uses pre-money or post-money language before negotiating.

SAFEs (Simple Agreements for Future Equity), widely used for pre-seed rounds, were historically pre-money instruments. In 2018, Y Combinator updated the standard SAFE to post-money. This was a material change — if you're raising on SAFEs, confirm which version you're using.

What VCs Actually Look For: 5 Factors That Justify a High Valuation

Valuation methods provide a framework, but deals get done on narrative. Here are the five factors that actually move a VC's number up:

1. Team pedigree and domain expertise.A founding team with a prior exit, deep domain experience, or technical credentials from top companies commands a meaningful premium. According to First Round Capital's analysis of their portfolio, founding team quality was the single strongest predictor of company outcomes.
2. Market size with a credible path to 10× return.VCs need their winners to return the fund. For a $150M fund, that means needing exits of $300M+ (2× fund) from a single investment. This only works in large markets. A founder who can credibly map a path from initial wedge to billion-dollar TAM gets a premium.
3. Traction and growth rate over absolute revenue.$30K MRR growing 25% month-over-month is more fundable than $200K MRR growing 5% per month. VCs model future revenue — growth rate is the input that matters most.
4. Defensibility and moat. Network effects, switching costs, proprietary data, or patents. If a competitor can replicate your product in 6 months, your valuation gets compressed. Show the moat.
5. Competitive term sheet dynamics.Nothing raises a valuation faster than a competing offer. According to Crunchbase data, deals with multiple term sheets close at a median 30–40% higher valuation than single-offer situations.

4 Common Founder Valuation Mistakes

1. Anchoring to a competitor's valuation without comparable metrics.If a competitor raised at a $50M valuation with $3M ARR growing 150% YoY, that multiple doesn't apply to your $300K ARR growing 40% YoY. VCs will see through it immediately.
2. Confusing post-money for pre-money on SAFEs.A $6M post-money SAFE cap when you've already raised $500K on prior SAFEs means the next equity round investors see you at a lower effective valuation than you think. Model the dilution before you sign.
3. Overweighting DCF projections. Founders sometimes build elaborate 5-year DCF models to justify high valuations. Experienced VCs discount these heavily because the assumptions are too uncertain. Use comparable methods instead.
4. Raising at a valuation that makes the next round impossible.A $20M pre-money seed round sounds great, but if you need to raise a Series A in 18 months, you'll need to hit $2–3M ARR to justify a meaningful step-up. Build in realistic milestones before accepting a high valuation.

Key Benchmarks for 2024–2026

These figures come from Crunchbase, PitchBook, and NVCA data published in 2024:

• Median pre-seed pre-money valuation (2024): $4–6M (Crunchbase)
• Median seed round size (2024): $3.1M (Crunchbase)
• Median Series A pre-money valuation (2024): $30–40M (PitchBook)
• Median Series A round size (2024): $12M (PitchBook)
• Median SaaS Series A ARR multiple (2024): ~10× (PitchBook)
• AI company premium over sector median (2024): 2–3× (NVCA)

These benchmarks shifted materially from 2021 (peak) to 2023 (trough) and have partially recovered. If you're using data older than 2023 for comp analysis, refresh it.

Frequently Asked Questions

What is a typical pre-seed startup valuation in 2024?

According to Crunchbase, the median pre-seed valuation in 2024 was approximately $4–6M pre-money. Solo founders or teams without a working prototype typically land lower; two technical co-founders with early traction can push above this range. Geography matters — Bay Area and NYC startups often carry a 20–40% premium over the national median.

What is the difference between pre-money and post-money valuation?

Pre-money valuation is what your company is worth before new investment. Post-money valuation adds the new capital on top. If a VC values your company at $8M pre-money and invests $2M, the post-money valuation is $10M and the VC owns 20%. Founders should always negotiate using pre-money figures — a $2M raise at $8M pre is very different from a $2M raise at $8M post.

How do VCs value a startup with no revenue?

For pre-revenue startups, VCs typically use the Berkus Method (up to $2.5M credit per milestone factor), Scorecard Method (benchmark valuation adjusted by team/market/traction scores), or Risk Factor Summation (starting from a benchmark and adjusting ±$250K per risk). The team and market size carry the most weight at this stage — revenue multiple methods don't apply until you have meaningful ARR.

What revenue multiple is used for SaaS Series A valuations?

At Series A in 2024–2026, SaaS companies typically raise at 8–15× ARR depending on growth rate, net revenue retention, and gross margins. Companies growing 100%+ year-over-year with 120%+ NRR can command the high end. PitchBook data shows the median SaaS Series A multiple compressed from 20× in 2021 to roughly 10× in 2024.

Does the Berkus Method still hold up in 2026?

The Berkus Method was designed for pre-revenue companies and caps total valuation at $2.5M per factor across five categories — sound idea, working prototype, quality management team, strategic relationships, and product rollout or sales. In today's market, these caps often feel conservative; many practitioners scale the method to $3–5M per factor to reflect current seed-round benchmarks.

Is DCF useful for early-stage startup valuation?

DCF is rarely used before Series A because early-stage startups lack reliable revenue projections. The model is highly sensitive to terminal growth assumptions, and small changes in the discount rate produce wildly different valuations. DCF becomes meaningful at Series B and beyond when companies have 2+ years of revenue history and a clearer path to profitability.